Upload
university-of-tennessee-memphis-obstetrics-and-gyncology
View
1.881
Download
0
Embed Size (px)
DESCRIPTION
asthma obgyn memphis pregnancy
Citation preview
Asthma: Current Concepts in Diagnosis and ManagementChristie F. Michael, MD
Assistant Professor
University of Tennessee, Memphis
Goals of Talk
Scope of asthmaDefinition/diagnosisNHLBI guidelines 2007Asthma in pregnancyOmalizumab
Asthma in Adults
14.7 million in US >10million office visits/yr ~1.9million ED visits/yr 466,000 hospitalizations/yr
Asthma Mortality
Asthma deaths: >5000 each year (1998,USA)
Asthma death in children 36% severe persistent 31% moderate persistent 33% mild persistent
The Good News
Mortality on decline despite increasing incidence
Most asthmatics can lead normal, active life with proper treatment
Asthma Definition
Obstructive lung disease with key features including partial reversibility, airway hyper-responsiveness and airway modeling
Davies, et al. Airway remodeling in asthma: new insights. JACI 2003; 111:215-25
Asthma: Expanding Definition
“A chronic inflammatory disorder of the airways in which many cells and cellular elements play a role…”
1.“Reversibility incomplete in some patients..”
2. Anti-inflammatory tx fails to prevent dz progression.
Airway Remodeling
Sub-basement fibrosis Mucus hypersecretion Epithelial injury Smooth muscle hypertrophy Angiogenesis
Not All That Wheezes Is Asthma…
-Foreign body- Upper airway diseases - Enlarged lymph nodes or tumor- Vocal cord dysfunction - Aspiration/GERD - COPD- CHF- PE- Drug reaction/side effect
Asthma Does Not Always Wheeze…
Chronic or nocturnal cough with awakenings
Exercise induced symptoms Chest tightness Viral induced symptoms
Asthma Diagnosis
Lower airway obstruction Variation in the magnitude of obstruction Recurrence of obstruction on more than
one occasion PFT’s/ peak flow variability Exclusion of alternative diagnoses
Diagnosis of Asthma
PFTs - FEV1 <80%
- Fev1/FVC
Ratio <65%
- >12%(200ml)
Reversibility in
FEV1 after B2
Agonist
Diagnosis of Asthma
Methacholine challenge:
Peak expiratory flow rate (PEFR):
Ht (cm) X 5.25-425
Gene by Environment
RSV in pediatrics Smoking/ smoke exposure Atopy Many others…
Link Between Asthma/Atopy:“One Airway, One Disease”
~80% asthmatics with allergic rhinitis 40% AR pts with asthma Of asymptomatic AR pts- up to 40% with
AHR Nasal allergen challenge increases AHR tx AR lowers asthma sx’s and related
costs
Guidelines for Asthma Diagnosis and Management
ASSESSMENT and MONITORING CONTRIBUTING FACTORS PATIENT EDUCATION PHARMACOTHERAPY
Asthma Severity Classification
Intrinsic intensity of dz process Used as the basis for selection of
therapy Incorporates subjective and objective
parameters Must apply with clinical judgement
Impairment AND Risk
Domains of both assessment and control
Current symptoms Future risk Objective and subjective measures
Impairment
Quality of life Missed school or work Surveys (ACT, ACQ..) Lung functions
Risk
Hospital stays/ICU ED visits Oral steroid bursts Lung function (FEV1, FEV1/FVC) Other biomarkers not proven (FeNO,
serum IgE, bld/sputum eos)
Assess Control
Once long-term control therapy initiated Responsiveness- the ease with which
control achieved Continue to assess impairment and risk
Guidelines for Asthma Diagnosis and Management
ASSESSMENT and MONITORING CONTRIBUTING FACTORS PATIENT EDUCATION PHARMACOTHERAPY
Precipitating Factors
Viral URIs Inhalant allergens- grasses, trees,
molds, pets, dust/dust mite, feather, cockroach
Food allergens- soy, wheat, milk, nuts, eggs
Irritant triggers- strong odors, smoke, cold air
Weather changes
Comorbid Conditions
Sinusitis Rhinitis Gastroesophageal reflux ABPA Vocal cord dysfunction OSA
Recognizing High-risk Asthmatics
Beta2-agonist over-use Disregard of symptoms Psychosocial factors Previous respiratory arrest or ICU admit
Asthma in Pregnancy
1/3 patients better1/3 stay the same1/3 worsen
Acute Treatment of Asthma
2 Agonists- PO, IV (albuterol, terbutaline) Anticholinergics- Ipatropium (Atrovent) Steroids- PO, IV (solumedrol, prednisone) Methylxanthines- PO, IV (Aminophylline,
Theophylline) Heliox (60/40) Magnesium Sulfate Intubation
Treatment of Asthma-Controller Therapy Inhaled Corticosteroids- gold standard Long-Acting B2 Agonists Leukotriene Modifiers Mast Cell Stabilizers Theophylline Omalizumab (Xolair) Immunotherapy
Inhaled corticosteroids
Preferred treatment for all classes of persistent asthma
Maximize benefit/ minimize risks combination therapies to minimize doses
(leukotriene modifiers, long acting beta2- agonists…)
Medications in Pregnancy
NASAL Pseudoephedrine (avoid in 1st trimester) Oxymetazoline nasal spray (3-5 days) Nasal steroids budesonide* beclomethasone Nasal saline irrigation Antihistamines chlorpheniramine cetirizine (after 1st trimester) loratadine (after 1st trimester)
Medications in Pregnancy
ASTHMA theophylline inhaled beta-agonists cromolyn prednisone (when indicated) inhaled steroids budesonide* beclomethasone
Anti- IgE Therapy: Omalizumab
XOLAIR multicenter, randomized, DBPCT, phase
III Anti-IgE reduces asthma exacerbations,
ED visits and hospitalization rates Adjunctive tx in poorly controlled
asthmatics and pt in need of IT but unable to tolerate due to severity of asthma
Anti-IgE: Qualifying for tx
Documented allergy to perennial allergen
Serum total IgE 30-700 Asthma
Referral Guidelines
Difficulty achieving/mx control Step 4 or higher Immunotherapy Omalizumab ICU stay